JAMA 2 July 2019 Volume 322 Number 1 Page 30
TANEZUMAB FOR PAINFUL OSTEOARTHRITIS
Jeffrey N. Katz MD MSc
New medications and therapeutics are always in progress and research continues. This article by Jeffrey Katz MD in the edition of JAMA cited above, makes comments on a new pharmaceutical currently in the pipeline.
The topic being discussed is that of osteoarthritis , a condition in which the pain and deterioration of the joints can be significant and eventually disabling.
He comments on the benefits and drawbacks of a new medication called TANEZUMAB. It is not currently available but is one of many approaches constantly sought for alleviating this common yet disabling malady.